Rethinking Where Patient Recruitment Begins
The patients are there. Our recruitment models just aren’t reaching them. Digital patient recruitment is proving to be not just an alternative, but an even more effective approach.
The patients are there. Our recruitment models just aren’t reaching them. Digital patient recruitment is proving to be not just an alternative, but an even more effective approach.
Mass General Brigham spun out a new company offering a generative AI platform that can rapidly interpret both structured and unstructured clinical data. Right now, the tool’s primary application is to accelerate and improve the accuracy of patient screening for clinical trials.
Arbiter’s Anjali Jameson on hospital and payer alignment.
In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity.
Cleveland Clinic is expanding its use of Dyania Health’s AI platform across the health system to speed up clinical trial recruitment. The system quickly scans patient records to identify eligible participants, aiming to give more patients access to trials and speed up development timelines for new therapies.
Micropayments provide an additional incentive for patients to complete required tests, procedures, and diary entries, ensuring that sites, sponsors, and CROs are able to collect the required data needed to complete a clinical trial on time and on budget.
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.
Paradigm, a new startup co-incubated by ARCH Venture Partners and General Catalyst, recently launched with $203 million in Series A funding. The company is focused on improving equitable access to trials by creating a less fragmented and more efficient clinical research ecosystem.
It is time to make it our collective mission to bring data automation to patient recruiting for clinical trials and not wait for a resolution of the pandemic to manage clinical trial disruption.
If the requirements are met, an effective AI-enhanced prescreening tool will allow more principal investigators to run clinical trials and more patients to gain access to potentially lifesaving treatments.
VitalTrax doesn't just inform patients about clinical trials, it gets them a seat at the table for possible enrollment. It's a win-win for sponsors and participants.